Polares Medical  Treating insufficiency in the function of the mitral valve

Polares’ approach has the potential to become the first-line treatment for patients with both functional and degenerative mitral regurgitation, the most common form of valvular heart disease.

Polares Medical is a clinical-stage company that is developing a unique minimally-invasive trans-catheter hemi-replacement system, PLAR system, to treat insufficiency in the function of the mitral valve. Polares’ PLAR system has demonstrated safety and clinical performance in patients under compassionate-use regulation, and the company has initiated the Early Feasibility studies in the US and Europe.


Medical Devices

Case facts


Switzerland, United States



Involved Team